BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 12684407)

  • 21. A haplotype analysis of HER-2 gene polymorphisms: association with breast cancer risk, HER-2 protein expression in the tumor, and disease recurrence in Korea.
    Han W; Kang D; Lee JE; Park IA; Choi JY; Lee KM; Bae JY; Kim S; Shin ES; Lee JE; Shin HJ; Kim SW; Kim SW; Noh DY
    Clin Cancer Res; 2005 Jul; 11(13):4775-8. PubMed ID: 16000574
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Association between polymorphisms of the BRCA2 gene and clinical parameters in breast cancer.
    Krupa R; Sliwinski T; Morawiec Z; Pawlowska E; Zadrozny M; Blasiak J
    Exp Oncol; 2009 Dec; 31(4):250-1. PubMed ID: 20010525
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The CYP19 gene codon 39 Trp/Arg polymorphism increases breast cancer risk in subsets of premenopausal Japanese.
    Hirose K; Matsuo K; Toyama T; Iwata H; Hamajima N; Tajima K
    Cancer Epidemiol Biomarkers Prev; 2004 Aug; 13(8):1407-11. PubMed ID: 15298966
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Disease family history and modification of breast cancer risk in common BRCA2 variants.
    Seymour IJ; Casadei S; Zampiga V; Rosato S; Danesi R; Falcini F; Strada M; Morini N; Naldoni C; Paradiso A; Tommasi S; Schittulli F; Amadori D; Calistri D
    Oncol Rep; 2008 Mar; 19(3):783-6. PubMed ID: 18288416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Association of interleukin-10 gene variation with breast cancer prognosis.
    Gerger A; Renner W; Langsenlehner T; Hofmann G; Knechtel G; Szkandera J; Samonigg H; Krippl P; Langsenlehner U
    Breast Cancer Res Treat; 2010 Feb; 119(3):701-5. PubMed ID: 19437115
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Effect of germ-line genetic variation on breast cancer survival in a population-based study.
    Goode EL; Dunning AM; Kuschel B; Healey CS; Day NE; Ponder BA; Easton DF; Pharoah PP
    Cancer Res; 2002 Jun; 62(11):3052-7. PubMed ID: 12036913
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The influence of serum HER-2 levels and HER-2 codon 655 polymorphism on breast cancer outcome.
    Papadopoulou E; Tripsianis G; Anagnostopoulos K; Tentes I; Kakolyris S; Galazios G; Sivridis E; Simopoulos K; Kortsaris A
    Neoplasma; 2008; 55(2):113-21. PubMed ID: 18237248
    [TBL] [Abstract][Full Text] [Related]  

  • 28. CASP8 polymorphisms, estrogen and progesterone receptor status, and breast cancer risk.
    Han S; Lee KM; Choi JY; Park SK; Lee JY; Lee JE; Noh DY; Ahn SH; Han W; Kim DH; Hong YC; Ha E; Yoo KY; Kang D
    Breast Cancer Res Treat; 2008 Jul; 110(2):387-93. PubMed ID: 17940865
    [TBL] [Abstract][Full Text] [Related]  

  • 29. DNA-repair genetic polymorphisms and breast cancer risk.
    Smith TR; Levine EA; Perrier ND; Miller MS; Freimanis RI; Lohman K; Case LD; Xu J; Mohrenweiser HW; Hu JJ
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1200-4. PubMed ID: 14652281
    [TBL] [Abstract][Full Text] [Related]  

  • 30. High expression of Wilms' tumor suppressor gene predicts poor prognosis in breast cancer patients.
    Miyoshi Y; Ando A; Egawa C; Taguchi T; Tamaki Y; Tamaki H; Sugiyama H; Noguchi S
    Clin Cancer Res; 2002 May; 8(5):1167-71. PubMed ID: 12006533
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Estrogen receptor codon 594 and HER2 codon 655 polymorphisms and breast cancer risk.
    Akisik E; Dalay N
    Exp Mol Pathol; 2004 Jun; 76(3):260-3. PubMed ID: 15126109
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The V89L polymorphism in the 5-alpha-reductase type 2 gene and risk of breast cancer.
    van Gils CH; Onland-Moret NC; Roest M; van Noord PA; Peeters PH
    Cancer Epidemiol Biomarkers Prev; 2003 Nov; 12(11 Pt 1):1194-9. PubMed ID: 14652280
    [TBL] [Abstract][Full Text] [Related]  

  • 33. HER-2/neu Ile655Val polymorphism and the risk of breast cancer.
    Siddig A; Mohamed AO; Kamal H; Awad S; Hassan AH; Zilahi E; Al-Haj M; Bernsen R; Adem A
    Ann N Y Acad Sci; 2008 Sep; 1138():84-94. PubMed ID: 18837888
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Retention of the p53 codon 72 arginine allele is associated with a reduction of disease-free and overall survival in arginine/proline heterozygous breast cancer patients.
    Bonafé M; Ceccarelli C; Farabegoli F; Santini D; Taffurelli M; Barbi C; Marzi E; Trapassi C; Storci G; Olivieri F; Franceschi C
    Clin Cancer Res; 2003 Oct; 9(13):4860-4. PubMed ID: 14581358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A prospective study of XRCC1 (X-ray cross-complementing group 1) polymorphisms and breast cancer risk.
    Patel AV; Calle EE; Pavluck AL; Feigelson HS; Thun MJ; Rodriguez C
    Breast Cancer Res; 2005; 7(6):R1168-73. PubMed ID: 16457697
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The effect of the I1307K APC polymorphism on the clinicopathological features and natural history of breast cancer.
    Yuan ZQ; Bégin LR; Wong N; Brunet JS; Trifiro M; Gordon PH; Pinsky L; Foulkes WD
    Br J Cancer; 1999 Nov; 81(5):850-4. PubMed ID: 10555757
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Polymorphisms in three base excision repair genes and breast cancer risk in Thai women.
    Sangrajrang S; Schmezer P; Burkholder I; Waas P; Boffetta P; Brennan P; Bartsch H; Wiangnon S; Popanda O
    Breast Cancer Res Treat; 2008 Sep; 111(2):279-88. PubMed ID: 17922186
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genetic susceptibility of catechol-O-methyltransferase polymorphism in Japanese patients with breast cancer.
    Inoue H; Shibuta K; Matsuyama A; Yoshinaga K; Sadanaga N; Ueo H; Barnard GF; Mori M
    Oncol Rep; 2005 Sep; 14(3):707-12. PubMed ID: 16077979
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The AIB1 glutamine repeat polymorphism is not associated with risk of breast cancer before age 40 years in Australian women.
    Montgomery KG; Chang JH; Gertig DM; Dite GS; McCredie MR; Giles GG; Southey MC; Hopper JL; Campbell IG
    Breast Cancer Res; 2005; 7(3):R353-6. PubMed ID: 15987430
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Allelic imbalance of HER-2 codon 655 polymorphism among different religious/ethnic populations of northern Greece and its association with the development and the malignant phenotype of breast cancer.
    Papadopoulou E; Simopoulos K; Tripsianis G; Tentes I; Anagnostopoulos K; Sivridis E; Galazios G; Kortsaris A
    Neoplasma; 2007; 54(5):365-73. PubMed ID: 17918664
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.